Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
BATON ROUGE, La., March 13, 2017 -- Amedisys, Inc. (NASDAQ:AMED) today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 27th Annual Oppenheimer Healthcare Conference in New York City, NY on Tuesday, March 21, 2017.
The presentation will begin at 2:45 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 340,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact: Amedisys, Inc. David Castille Managing Director, Finance 225.299.3665 [email protected]
